{{Rsnum
|rsid=1494373
|Gene=MOSC2
|Chromosome=1
|position=220756014
|Orientation=minus
|GMAF=0.1708
|Gene_s=MARC2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 75.0 | 23.2 | 1.8
| HCB | 59.1 | 34.3 | 6.6
| JPT | 50.4 | 45.1 | 4.4
| YRI | 97.3 | 2.7 | 0.0
| ASW | 84.2 | 15.8 | 0.0
| CHB | 59.1 | 34.3 | 6.6
| CHD | 66.7 | 28.7 | 4.6
| GIH | 65.3 | 32.7 | 2.0
| LWK | 90.9 | 9.1 | 0.0
| MEX | 46.6 | 46.6 | 6.9
| MKK | 86.3 | 13.7 | 0.0
| TSI | 68.6 | 30.4 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19875103
|Trait=Response to antipsychotic therapy (extrapyramidal side effects)
|Title=Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects
|RiskAllele=
|Pval=0.000006
|OR=NR
|ORtxt=NR
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1494373
|overall_frequency_n=14
|overall_frequency_d=128
|overall_frequency=0.109375
|n_genomes=11
|n_genomes_annotated=0
|n_haplomes=11
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}